Significance and expression of p-Akt in oral squamous cell carcinoma

Background: Oral cancer is considered as the sixth-most common malignant neoplasm in the world and the most common type is squamous cell carcinoma (SCC). Akt is a serine/threonine-protein kinase, that acts in the regulation of different signaling downstream pathways, including; proliferation, growth, cell metabolism, angiogenesis and survival. The objective of the present study was to show the expression of p-Akt and its prognostic effect in oral SCC (OSCC). Materials and Methods: A total of 72 cases of OSCC were included in this study; the expression of the Akt gene was done on 4 μm tumor sections using immunohistochemical staining of Akt antibody. Results: Histopathological examination showed that: (43) were GIII, (13) cases were GII, and (16) cases were GI. The positivity of immunohistochemical staining were appear as brown stain. Results showed increase expression of p-Akt in most cases of oral SCC and mean expression about (54.86 ± 31.58), and the expression of p-Akt was increased with the progression of the histological grade of the tumor. Conclusion: High expression of p-Akt and its relation with the progression of tumor grade and invasion of tumor may indicate the relationship between p-Akt expression and aggressiveness and progression of the tumor.

[1]  A. Kunnumakkara,et al.  Isoform-Specific Role of Akt in Oral Squamous Cell Carcinoma , 2019, Biomolecules.

[2]  R. Purohit,et al.  Cancer Associated E17K Mutation Causes Rapid Conformational Drift in AKT1 Pleckstrin Homology (PH) Domain , 2013, PloS one.

[3]  A. Ullrich,et al.  Regulation of Akt(ser473) phosphorylation by Choline kinase in breast carcinoma cells , 2009, Molecular Cancer.

[4]  A. Iamaroon,et al.  Overexpression and activation of Akt2 protein in oral squamous cell carcinoma. , 2009, Oral oncology.

[5]  H. Pontes,et al.  Metallothionein and p-Akt proteins in oral dysplasia and in oral squamous cell carcinoma: an immunohistochemical study. , 2009, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[6]  J. Testa,et al.  AKT signaling in normal and malignant cells , 2005, Oncogene.

[7]  W. Sellers,et al.  Akt-regulated pathways in prostate cancer , 2005, Oncogene.

[8]  J. Kim,et al.  Prognostic value of activated Akt expression in oral squamous cell carcinoma , 2005, Journal of Clinical Pathology.

[9]  P. Scardino,et al.  High Levels of Phosphorylated Form of Akt-1 in Prostate Cancer and Non-Neoplastic Prostate Tissues Are Strong Predictors of Biochemical Recurrence , 2004, Clinical Cancer Research.

[10]  D. Schuller,et al.  Disease control, survival, and functional outcome after multimodal treatment for advanced‐stage tongue base cancer , 2004, Head & neck.

[11]  J. Jett,et al.  Phospho-Akt overexpression in non-small cell lung cancer confers significant stage-independent survival disadvantage. , 2004, Clinical cancer research : an official journal of the American Association for Cancer Research.

[12]  P. Dhawan,et al.  Constitutive activation of Akt/protein kinase B in melanoma leads to up-regulation of nuclear factor-kappaB and tumor progression. , 2002, Cancer research.

[13]  C. Sawyers,et al.  The phosphatidylinositol 3-Kinase–AKT pathway in human cancer , 2002, Nature Reviews Cancer.

[14]  K. M. Nicholson,et al.  The protein kinase B/Akt signalling pathway in human malignancy. , 2002, Cellular signalling.

[15]  R. Gilbert,et al.  Current treatment options in squamous cell carcinoma of the oral cavity. , 2004, Surgical oncology clinics of North America.